TILC - ETF AI Analysis
Top Page
Thrivent International Large Cap ETF (TILC)
Rating:62Neutral
Price Target:―
Positive Factors
Strong Leading Holding
The largest position, ASML Holding, has shown strong performance so far this year, helping support the fund’s overall returns.
Broad International Diversification
The ETF spreads its investments across many countries such as Japan, the UK, France, Australia, and others, which helps reduce the impact of problems in any single market.
Mix of Defensive and Cyclical Sectors
Holdings across financials, industrials, health care, energy, and other sectors provide a balance between growth opportunities and more stable, defensive areas.
Negative Factors
Moderate Fee Level
The expense ratio is not especially low, meaning a noticeable portion of returns goes toward fees each year.
Recent Short-Term Weakness
The ETF has shown weak performance over the past month, which may signal near-term volatility for investors.
Exposure to Lagging Top Holding
One of the top positions, Sanofi, has been lagging this year, which can slightly drag on the fund’s overall performance.
TILC vs. SPDR S&P 500 ETF (SPY)
AUM872.70M
RegionDeveloped Markets
Expense Ratio0.52%
Beta0.66
IssuerThrivent
Inception DateJun 15, 2026
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume108,440
30 Day Avg. Volume25,599
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
28.87Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering308
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TILC Summary
Thrivent International Large Cap ETF (TILC) is an international stock fund that focuses on large, well-established companies outside the U.S., rather than tracking a specific index. It spreads investments across many countries like Japan, the UK, and France, and across sectors such as financials, industrials, and health care. Well-known holdings include ASML Holding and Novartis. Someone might invest in TILC to diversify beyond U.S. stocks and tap into long-term growth in developed markets overseas. A key risk is that the fund’s value can rise or fall with global markets and foreign currency swings.
How much will it cost me?This ETF has an expense ratio of 0.52%, which means you’ll pay about $5.20 per year for every $1,000 you invest. That’s higher than the average low-cost index ETF because this fund is actively managed, which typically involves more research and trading.
What would affect this ETF?This ETF could benefit if developed markets outside the U.S. grow steadily, especially in areas like technology, health care, and industrials where top holdings such as ASML, Novartis, and ABB operate, and if global trade and energy demand support companies like BHP and Shell. On the other hand, slower economic growth abroad, rising interest rates that pressure financial firms like Allianz and BNP Paribas, currency swings, or geopolitical tensions in Europe or Asia could hurt returns for this international large-cap fund.
TILC Top 10 Holdings
TILC leans heavily on European health care and industrial heavyweights, with ASML and ABB acting as key engines of growth thanks to their rising, tech-and-automation-driven momentum. Shell and BHP add an energy and materials backbone, with performance that’s been mostly supportive but occasionally choppy. On the defensive side, Novartis, Roche, and GSK provide steady ballast, even as Sanofi has been lagging and quietly weighing on returns. Overall, the fund is a developed-markets ex-U.S. play, anchored in Europe with diversified sector exposure but a clear tilt toward health care and industrial leaders.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.31% | $30.16M | €581.61B | 86.21% | 76 Outperform | |
| Novartis AG | 2.10% | $19.13M | CHF219.30B | 22.56% | 80 Outperform | |
| Roche Holding AG | 1.94% | $17.63M | $346.33B | 37.61% | 73 Outperform | |
| Shell (UK) | 1.80% | $16.41M | £206.26B | 35.55% | 73 Outperform | |
| ABB Ltd | 1.61% | $14.69M | kr1.72T | 39.88% | 78 Outperform | |
| BHP Group Ltd | 1.60% | $14.61M | AU$308.67B | 50.00% | 68 Neutral | |
| NatWest Group | 1.37% | $12.48M | £55.08B | 32.95% | 75 Outperform | |
| Investor AB | 1.37% | $12.44M | kr1.25T | 40.53% | 77 Outperform | |
| GlaxoSmithKline | 1.31% | $11.88M | £74.17B | 22.53% | 77 Outperform | |
| TotalEnergies SE | 1.20% | $10.96M | €178.55B | 52.40% | 78 Outperform |
TILC Technical Analysis
Negative
―
Price Trends
25.70
Negative
Market Momentum
-0.12
Positive
42.13
Neutral
26.23
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TILC, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 25.60, equal to the 50-day MA of 25.70, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of -0.12 indicates Positive momentum. The RSI at 42.13 is Neutral, neither overbought nor oversold. The STOCH value of 26.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TILC.
TILC Peer Comparison
Comparison Results
Performance Comparison
TILC
Thrivent International Large Cap ETF
25.25
-0.13
-0.51%
FYLD
Cambria Foreign Shareholder Yield ETF
―
―
―
TXUE
Thornburg International Equity ETF
―
―
―
AVSD
Avantis Responsible International Equity ETF
―
―
―
NBIE
Neuberger International Core Equity ETF
―
―
―
TLCI
Touchstone International Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents